New York State Teachers Retirement System (NYSTRS)
TRDA icon

New York State Teachers Retirement System (NYSTRS)’s Entrada Therapeutics TRDA Stock Holding History

New York State Teachers Retirement System (NYSTRS)’s Portfolio TRDA Stock Details TRDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,915
Closed -$27K – 1658
2024
Q1 		$27K Buy
+1,915
New +$27.1K ﹤0.01% 1597

Other funds holding TRDA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS)'s TRDA Position: Q2 2024 in Review

New York State Teachers Retirement System (NYSTRS) sold out of Entrada Therapeutics (TRDA) in Q2 2024, closing a stake of 1,915 shares — an estimated $27K sold.

New York State Teachers Retirement System (NYSTRS) first reported a position in TRDA in Q1 2024 and held it in 1 quarter. The position peaked at $27K in Q1 2024. 83 funds tracked by Wall St. Rank hold TRDA as of Q2 2024.

  • New York State Teachers Retirement System (NYSTRS) reported no remaining Entrada Therapeutics position as of Q2 2024 after selling out during the quarter.
  • New York State Teachers Retirement System (NYSTRS) sold 1,915 Entrada Therapeutics shares in Q2 2024, an estimated $27K.
  • New York State Teachers Retirement System (NYSTRS) first reported a position in Entrada Therapeutics in Q1 2024 and held it in 1 quarter.
  • New York State Teachers Retirement System (NYSTRS)'s Entrada Therapeutics position peaked at $27K in Q1 2024.
  • 83 funds tracked by Wall St. Rank held Entrada Therapeutics as of Q2 2024.

Based on New York State Teachers Retirement System (NYSTRS)'s 13F filing for Q2 2024, filed 24 Jul 2024.